TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $3.41M2011: $1.57M2012: $6.51M2013: $56.54M2014: $85.04M2015: $77.34M2016: $38.16M2017: $34.47M2018: $36.97M2019: $166.13M2020: $304.96M2021: $208.89M2022: $124.78M2023: $82.25M2024: $144.76M2025: $167.85M$167.85M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$167.85M+16.0%
2024$144.76M+76.0%
2023$82.25M-34.1%
2022$124.78M-40.3%
2021$208.89M-31.5%
2020$304.96M+83.6%
2019$166.13M+349.3%
2018$36.97M+7.3%
2017$34.47M-9.7%
2016$38.16M-50.7%
2015$77.34M-9.1%
2014$85.04M+50.4%
2013$56.54M+768.2%
2012$6.51M+314.5%
2011$1.57M-54.0%
2010$3.41M—